Infection in the pathogenesis of preterm labor

Seminars in Perinatology

Volumn 12, Issue 4, 1988, Pages 262-279

  Romero, Roberto ^a,b   Mazor, Moshe ^a,b   Ying King Wu, ^a,b   Sirtori, Marina ^a,b   Oyarzun, Enrique ^a,b   Mitchell, Murray D ^a,b   Hobbins, John C ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYICOSATETRAENOIC ACID; PROSTAGLANDIN F;

BACTERIAL INFECTION; FEMALE; HUMAN; MICROBIOLOGY; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; REVIEW; URINARY TRACT; UTERINE CERVIX; UTERUS DISEASE; VAGINA;

BACTERIAL INFECTIONS; CERVIX UTERI; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMAN; HYDROXYEICOSATETRAENOIC ACIDS; LABOR, PREMATURE; PREGNANCY; PROSTAGLANDINS F; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; URINARY TRACT; UTERINE DISEASES; VAGINA;

EID: 0024098272     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (163)

1. Management of acute chorioamnionitis
2. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term
3. The placenta and membranes
4. Fetal and maternal features of antenatal bacterial infections
5. Causes and consequences of premature rupture of fetal membranes
6. How to improve your amniocentesis technique
7. Infection and preterm labor
8. Infection amniotique et neonatal
9. Amniotic infection syndrome pathogenesis morphology and significance in circumnatal mortality
10. Pathways of fetal and early neonatal infection Viral placentitis bacterial and fungal chorioamnionitis
11. Intrauterine bacterial infection of the newborn infant
12. Pathology and the developing fetus
13. Routes and types of infection in the fetus and the newborn
14. Bacterial attachment to the chorioamniotic membranes
15. Antimicrobial activity of amniotic fluid against Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum
16. Bacterial colonization of amniotic fluid from intact fetal membranes
17. Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor
18. Amniocentesis in the evaluation of premature labor
19. Silent chorioamnionitis as a cause of preterm labor refractory to tocolytic therapy
20. Intra-amniotic bacterial colonization in premature labor
21. Evaluation of amniotic fluid in preterm labor with intact membranes
22. Amniocentesis and the management of premature labor
23. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis
24. Does extra-amniotic infection cause preterm labor? Gas-liquid chromatography studies of amniotic fluid in amnionitis, preterm labor, and normal controls
25. Subclinical intra-amniotic infection in asymptomatic patients with refractory preterm labor
26. The value and limitations of the gram stain examination in the diagnosis of intraamniotic infection
27. The use of amniocentesis in patients with premature rupture of membranes
28. Chorioamnionitis in the preterm gestation
29. Use of amniocentesis in preterm gestation with ruptured membranes
30. Amniocentesis for gram stain and culture in preterm premature rupture of the membranes
31. Qualitative amniotic fluid volume versus amniocentesis in predicting infection in preterm rupture of the membranes
32. Amniocentesis with premature rupture of membranes
33. Amniotic fluid volume as a risk factor in preterm premature rupture of the membranes
34. Intraamniotic infection and the onset of labor in preterm premature rupture of membranes
35. The value of umbilical cord histology in the management of potential perinatal infection
36. Placental inflammation and infection: A prospective bacteriologic and histologic study
37. Placental microbiology and histology and the pathogenesis of chorioamnionitis
38. Chorioamnionitis and funiculitis in the placentas of 200 births weighing less than 2.5 kg
39. The microbiologic significance of pathologic placental chorioamnionitis. Abstract #55
40. Inflammatory lesions of the human placenta: Clinical significance of acute chorioamnionitis
41. The association of chorioamnionitis with preterm delivery
42. The role of infection in the etiology of preterm birth
43. Premature rupture of membranes and spontaneous preterm labor: Maternal endometritis risks
44. The occurrence during acute infections of a protein not normally present in blood
45. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus
46. The liver as the site of C-reactive protein formation
47. Effect of leukocytic endogenous mediator on C-reactive protein in rabbits
48. The diagnostic utility of C-reactive protein
49. Clinical relevance of interleukin-1 and its multiple biological activities
50. Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression
51. C-reactive protein as a predictor of infectious morbidity with premature rupture of membranes
52. C-reactive protein with premature rupture of membranes and premature labor
53. Premature rupture of membranes: The role of C-reactive protein in the prediction of chorioamnionitis
54. C-reactive protein as a predictor for chorioamnionitis in cases of premature rupture of the membranes
55. Correlation of maternal serum C-reactive protein with outcome of tocolysis
56. The association of subclinical infection with preterm labor: The role of C-reactive protein
57. Maternal C-reactive protein and preterm labor
58. Changes in the pattern of neonatal septicemia and meningitis
59. Septicemia in premature infants
60. Role of prostaglandins, prostacyclin, and thromboxanes in the physiologic control of the uterus and in parturition
61. The mechanism(s) of human parturition
62. Initiation of human parturition 1: Mechanism of action of arachidonic acid
63. F prostaglandin levels in amniotic fluid in premature labour
64. Plasma concentrations of prostaglandins during late human pregnancy: Influence of normal and preterm labor
65. A comparison of plasma prostaglandin levels in term and preterm labour
66. Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor
67. Prostaglandin F metabolite concentration as a prognostic factor in preterm labor
68. Concentrations of prostaglandins in amniotic fluid in premature labor
69. Biosynthesis of prostaglandin in human decidua, amnion, chorion, and villi
70. 2 by tissues from the human uterus and foeto-placenta unit
71. Specific production of prostaglandin E by human amnion in vitro
72. Increased concentrations of arachidonic acid lipoxygenase metabolites in amniotic fluid during parturition
73. Increased amniotic fluid leukotriene C, concentration in term human parturition
74. Smooth muscle contraction as a model to study the mediator role of endogenous lipoxygenase products of arachidonic acid
75. The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility
76. Involvement of lipoxygenase products in myometrial contractions
77. Premature labor: Bacterial sources of phospholipase
78. Effects of bacterial production on prostaglandin E production by amnion cells
79. Preterm labor: Stimulation of arachidonic acid metabolism in human amnion by bacterial products
80. Infection and labor: The detection of endotoxin in amniotic fluid
81. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages
82. 2 production by human amnion
83. Labor and infection 11. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor
84. Interleukin-1
85. Interleukin-1 and the pathogenesis of the acute phase response
86. Stimulation of rheumatoid synovial cell collegenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin-1)
87. 2 release increased degradation of muscle proteins during fever
88. Prostacyclin synthesis induced in vascular cells by interleukin-1
89. Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: Role of monokines and interleukin-1
90. The stimulations of arachidonic acid metabolism by recombinant murine interleukin-1 and tumor promoters or 1-oleoyl-2-acetyl-glycerol are synergistic
91. Synergistic stimulation of fibroblast prostaglandin production by recombinant and tumor necrosis factor
92. Stimulation of arachidonic acid metabolism: Differences in potencies of recombinant human interleukin-1 on two cell types
93. Interleukin-1: A signal for the initiation of labor in chorioamnionitis
94. Human decidua: A potent source of interleukin-l-like activity
95. Tumor necrosis factor: A signal for the initiation of labor in chorioamnionitis
96. Bacteriuria and pyelonephritis of pregnancy
97. Bacteriuria in pregnancy
98. Bacteriuria of pregnancy
99. Pyelonephritis and bacteriuria A major problem in preventative medicine
100. Effect of bacteriuria on the fetus
101. The significance of bacteriuria in pregnancy
102. Demographic and prognostic characteristics of bacteriuria in pregnancy
103. The management and complications of asymptomatic bacteriuria in pregnancy
104. The effect of tetracycline on the clinical course and the outcome of pregnancy
105. The effects of bacteriuria in pregnancy on maternal and fetal health
106. Asymptomatic bacteriuria in pregnancy and its association with prematurity
107. The impact of bacteriuria in pregnancy—A survey of 1,300 pregnant patients
108. Antibiotic elimination of group B streptococci in urine in prevention of preterm labour
109. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women
110. Infectious processes and preterm labor
111. Symptomatic gonorrhea during pregnancy
112. Neonatal gonococcal infection Orogastric contamination with Neisseria gonorrhea
113. Asymptomatic gonorrhea and pregnancy
114. Gonorrhea in pregnancy
115. Treated maternal gonorrhea without adverse effect on outcome of pregnancy
116. Bacterial vaginosis during pregnancy: An association with prematurity and postpartum complications
117. Toxonomy of vaginosis: Bacterial vaginosis-A definition
118. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome
119. Relationships of vaginal lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth
120. Risk factors for prematurity and premature rupture of membranes: A prospective study of the vaginal flora in pregnancy
121. The influence of advancing gestation on group B streptococcal colonization in pregnant women
122. Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers
123. Group B streptococcal colonization and the outcome of pregnancy
124. Perinatal complications in group B streptococcal carriers: A longitudinal study of prenatal patients
125. Spontaneous early preterm labour associated with abnormal genital bacterial colonization
126. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections
127. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy: Epidemiology and outcomes
128. Microbiological studies during the perinatal period: An attempt to correlate selected bacterial and viral infections with intrauterine deaths and preterm labour
129. Chlamydia trachomatis infection and pregnancy outcome
130. Colonization of newborn infants by mycoplasmas
131. Isolation of Mycoplasma hominis, T-strains, and cytomegalovirus from the cervix of pregnant women
132. Birth weight and genital mycoplasmas in pregnancy
133. Genital mycoplasmas and birth weight in offspring of primigravida women
134. The effect of genital mycoplasmas on human fetal growth
135. Genital mycoplasmas as a cause of excess premature delivery
136. The role of mycoplasmas in reproduction
137. Effect on birth weight of erythromycin treatment of pregnant women
138. Chorioamnionitis and colonization of the newborn infant with genital mycoplasmas
139. Genital mycoplasma infection: Intrauterine infection, pathologic study of the fetus and placenta
140. Placental infection with mycoplasma hominis and Ureaplasma urealyticum: Clinical correlation
141. Ureaplasma urealyticum incriminated in perinatal morbidity and mortality
142. Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality
143. Chorionic mycoplasmas and prematurity
144. Trichomonas in pregnancy
145. Trichomonas infection in pregnancy-Does it affect perinatal outcome?
146. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome
147. Treatment of chlamydia, mycoplasma, and group B streptococcal infections
148. Adjunctive erythromycin treatment for idiopathic preterm labor: Results of a randomized, double-blinded, placebo-controlled trial
149. Premature rupture of membranes managed with a new cervical catheter
150. Transcervical amnioinfusion of antibiotics: A basic study for managing premature rupture of membranes
151. Use of parenteral antibiotic therapy to eradicate bacterial colonization of amniotic fluid in premature rupture of membranes